Dr. Wen-Fang Cheng, MD
Claim this profileNational Taiwan University Hospital
Studies Stomach Cancer
Studies Ovarian Cancer
1 reported clinical trial
3 drugs studied
Area of expertise
1Stomach Cancer
Stage III
Stage IV
2Ovarian Cancer
Stage III
Stage IV
More about Wen-Fang Cheng, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Wen-Fang Cheng, MD has experience with
- Carboplatin
- Oregovomab
- Paclitaxel
Breakdown of trials Wen-Fang Cheng, MD has run
Stomach Cancer
Ovarian Cancer
Uterine Tumors
Peritoneal Carcinomatosis
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Wen-Fang Cheng, MD specialize in?
Wen-Fang Cheng, MD focuses on Stomach Cancer and Ovarian Cancer. In particular, much of their work with Stomach Cancer has involved Stage III patients, or patients who are Stage IV.
Is Wen-Fang Cheng, MD currently recruiting for clinical trials?
No, Wen-Fang Cheng, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Wen-Fang Cheng, MD has studied deeply?
Yes, Wen-Fang Cheng, MD has studied treatments such as Carboplatin, Oregovomab, Paclitaxel.
What is the best way to schedule an appointment with Wen-Fang Cheng, MD?
Apply for one of the trials that Wen-Fang Cheng, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.